GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Newron Pharmaceuticals SpA (XTER:NP5) » Definitions » Cyclically Adjusted PB Ratio

Newron Pharmaceuticals SpA (XTER:NP5) Cyclically Adjusted PB Ratio : 3.83 (As of Oct. 31, 2024)


View and export this data going back to . Start your Free Trial

What is Newron Pharmaceuticals SpA Cyclically Adjusted PB Ratio?

As of today (2024-10-31), Newron Pharmaceuticals SpA's current share price is €8.89. Newron Pharmaceuticals SpA's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec23 was €2.32. Newron Pharmaceuticals SpA's Cyclically Adjusted PB Ratio for today is 3.83.

The historical rank and industry rank for Newron Pharmaceuticals SpA's Cyclically Adjusted PB Ratio or its related term are showing as below:

XTER:NP5' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.43   Med: 2.24   Max: 4.95
Current: 4.02

During the past 13 years, Newron Pharmaceuticals SpA's highest Cyclically Adjusted PB Ratio was 4.95. The lowest was 0.43. And the median was 2.24.

XTER:NP5's Cyclically Adjusted PB Ratio is ranked worse than
73.02% of 593 companies
in the Biotechnology industry
Industry Median: 1.62 vs XTER:NP5: 4.02

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Newron Pharmaceuticals SpA's adjusted book value per share data of for the fiscal year that ended in Dec23 was €-1.676. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €2.32 for the trailing ten years ended in Dec23.

Shiller PE for Stocks: The True Measure of Stock Valuation


Newron Pharmaceuticals SpA Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Newron Pharmaceuticals SpA's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Newron Pharmaceuticals SpA Cyclically Adjusted PB Ratio Chart

Newron Pharmaceuticals SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.25 0.80 0.60 0.60 2.29

Newron Pharmaceuticals SpA Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.60 - 2.29 -

Competitive Comparison of Newron Pharmaceuticals SpA's Cyclically Adjusted PB Ratio

For the Biotechnology subindustry, Newron Pharmaceuticals SpA's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Newron Pharmaceuticals SpA's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Newron Pharmaceuticals SpA's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Newron Pharmaceuticals SpA's Cyclically Adjusted PB Ratio falls into.



Newron Pharmaceuticals SpA Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Newron Pharmaceuticals SpA's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=8.89/2.32
=3.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Newron Pharmaceuticals SpA's Cyclically Adjusted Book per Share for the fiscal year that ended in Dec23 is calculated as:

For example, Newron Pharmaceuticals SpA's adjusted Book Value per Share data for the fiscal year that ended in Dec23 was:

Adj_Book=Book Value per Share/CPI of Dec23 (Change)*Current CPI (Dec23)
=-1.676/119.7000*119.7000
=-1.676

Current CPI (Dec23) = 119.7000.

Newron Pharmaceuticals SpA Annual Data

Book Value per Share CPI Adj_Book
201412 2.244 99.721 2.694
201512 2.610 99.814 3.130
201612 3.154 100.300 3.764
201712 3.797 101.200 4.491
201812 3.073 102.300 3.596
201912 2.062 102.800 2.401
202012 0.966 102.600 1.127
202112 0.174 106.600 0.195
202212 -0.786 119.000 -0.791
202312 -1.676 119.700 -1.676

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Newron Pharmaceuticals SpA  (XTER:NP5) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Newron Pharmaceuticals SpA Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Newron Pharmaceuticals SpA's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Newron Pharmaceuticals SpA Business Description

Traded in Other Exchanges
Address
Via Antonio Meucci 3, Bresso, Milan, ITA, 20091
Newron Pharmaceuticals SpA is a biopharmaceutical company focused on the development of therapies for patients with diseases of the central and peripheral nervous system. Geographically the research and development activities are performed in Italy and the United States.
Executives
Stefan Weber Board of Directors
Dr. Ulrich Köstlin Supervisory Board

Newron Pharmaceuticals SpA Headlines

No Headlines